BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1715401)

  • 1. Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques.
    Kawashima Y; Niwa T; Takeuchi H; Hino T; Itoh Y; Furuyama S
    J Pharm Sci; 1991 May; 80(5):472-8. PubMed ID: 1715401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
    Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates.
    van Tonder EC; Maleka TS; Liebenberg W; Song M; Wurster DE; de Villiers MM
    Int J Pharm; 2004 Jan; 269(2):417-32. PubMed ID: 14706253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties.
    Otsuka M; Ofusa T; Matsuda Y
    Drug Dev Ind Pharm; 1999 Feb; 25(2):197-203. PubMed ID: 10065353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RH-temperature stability diagram of α- and β-anhydrous and monohydrate lactose crystalline forms.
    Allan MC; Grush E; Mauer LJ
    Food Res Int; 2020 Jan; 127():108717. PubMed ID: 31882085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of polymorphism and solvation in tranilast.
    Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
    J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of spherically agglomerated crystals of aminophylline.
    Kawashima Y; Aoki S; Takenaka H; Miyake Y
    J Pharm Sci; 1984 Oct; 73(10):1407-10. PubMed ID: 6502490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct preparation of spherically agglomerated salicylic acid crystals during crystallization.
    Kawashima Y; Okumura M; Takenaka H; Kojima A
    J Pharm Sci; 1984 Nov; 73(11):1535-8. PubMed ID: 6520752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed solvent system for preparation of spherically agglomerated crystals of ascorbic acid.
    Ren F; Zhou Y; Liu Y; Fu J; Jing Q; Ren G
    Pharm Dev Technol; 2017 Sep; 22(6):818-826. PubMed ID: 27402196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
    Dalvadi H; Parmar K; Yadav S
    Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability.
    Hu D; Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2023 Mar; 635():122707. PubMed ID: 36764418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of surface characteristics of theophylline anhydrate powder on hygroscopic stability.
    Otsuka M; Kaneniwa N; Kawakami K; Umezawa O
    J Pharm Pharmacol; 1990 Sep; 42(9):606-10. PubMed ID: 1981897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical characterization of nedocromil sodium hydrates.
    Khankari R; Chen L; Grant DJ
    J Pharm Sci; 1998 Sep; 87(9):1052-61. PubMed ID: 9724554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.